ORAMED PHARMACEUTICALS INC. (37) | Business Finance (10)
Browse by Subcategory
Recent Contracts
-
Form of Securities Purchase Agreement, dated as of November 3, 2021 between the Company and each Purchaser in the Offering
(Filed With SEC on November 4, 2021)
-
Equity Distribution Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co
(Filed With SEC on September 1, 2021)
-
Underwriting Agreement, dated February 27, 2020, between Oramed Pharmaceuticals Inc. and National Securities Corporation
(Filed With SEC on February 28, 2020)
-
Form of Underwriters Warrant
(Filed With SEC on February 28, 2020)
-
Form of Notice of Stock Option Award and Stock Option Award Agreement
(Filed With SEC on November 27, 2019)
-
Equity Distribution Agreement, dated July 15, 2021, by and between the Company and Canaccord Genuity
(Filed With SEC on July 15, 2021)
-
Equity Distribution Agreement, dated June 16, 2021, by and between the Company and Canaccord Genuity
(Filed With SEC on June 16, 2021)
-
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity
(Filed With SEC on December 1, 2020)
-
Amendment to the Equity Distribution Agreement, dated February 10, 2020, between Canaccord Genuity LLC and Oramed Pharmaceuticals Inc
(Filed With SEC on April 6, 2020)
-
Equity Distribution Agreement, dated September 5, 2019, by and between the Company and Canaccord Genuity
(Filed With SEC on September 5, 2019)